|
LBRX LB Pharmaceuticals Inc 1691082 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-51,603,000.00 |
| Balance Sheet |
|
Current Assets
|
$355,301,000.00 |
|
Assets
|
$361,692,000.00 |
|
Current Liabilities
|
$23,564,000.00 |
|
Liabilities
|
$29,345,000.00 |
|
Equity
|
$332,347,000.00 |
|
Shares Out
|
28681063.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-60,919,000.00 |
|
Investing Cash Flow
|
$57,000.00 |
| Market Analysis |
Market Cap
|
$1,354,606,605.49 |
|
Price
|
$47.23 |
|
BVPS
|
11.59 |
|
PB
|
4.08 |
|
EPS
|
-1.71 |
|
FCF
|
$-61,314,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-12 |
-0.67 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LBRX documents filed with the SEC.
LBRX Filings
Clear
